PT-141, also known as bremelanotide, is a synthetic melanocortin peptide that appears frequently in the research literature on melanocortin-receptor signaling. For laboratories evaluating compounds for experimental work, understanding what PT-141 is, how it is characterized, and what researchers have examined provides a useful starting point. This overview looks at PT-141 strictly from a research perspective.
Before going further, an important note: the information here is educational and intended for those handling compounds in a controlled laboratory setting. PT-141 discussed here is a research compound for research use only. It is not a drug, cosmetic, food, or supplement, and it is not intended for human or animal use, diagnosis, or treatment.
What Is PT-141?
PT-141 (bremelanotide) is a synthetic cyclic peptide derived from the melanocortin family, structurally related to a metabolite of melanotan II. It is studied as a melanocortin-receptor agonist, with particular research interest in the MC4 receptor. Its defined, cyclic structure makes it a reproducible subject for receptor-pharmacology work.
Molecular Characteristics
PT-141 is a small cyclic heptapeptide with a molecular weight in the low thousands of daltons. Its cyclic structure contributes to stability and receptor selectivity relative to linear analogs. Identity and purity are typically confirmed by mass spectrometry and reversed-phase HPLC, which distinguish the intended cyclic sequence from linear or truncated byproducts of synthesis.
Mechanisms Studied in Research
In experimental models, PT-141 is studied as an agonist at melanocortin receptors, especially MC4R, which is implicated in central nervous system signaling pathways. Research has examined receptor binding, downstream signaling, and behavioral readouts in animal models. These are model-based observations within defined experimental systems and are not statements about outcomes in humans.
Research Applications
PT-141 appears most often in preclinical neuropharmacology and receptor-signaling studies within the melanocortin system. It is frequently used as a reference agonist in MC4R-focused assays. Laboratories comparing melanocortin compounds rely on well-documented reference material, which makes vendor quality assessment part of study design; our GMP and certificate-of-analysis checklist outlines what to verify.
Stability, Handling, and Storage
Like most research peptides, PT-141 is generally handled lyophilized, kept cold, dry, and protected from light, with freeze-thaw cycles minimized after reconstitution. Its cyclic structure aids stability, but documenting reconstitution solvent, concentration, and storage temperature remains important for reproducibility across experiments.
Purity and Quality Verification
Cyclic peptides can carry impurities from incomplete cyclization or side reactions, so purity assessment matters. HPLC purity percentage, mass-spectrometric identity confirmation, and content analysis are standard. Reviewing a certificate of analysis before use lets a laboratory confirm identity and purity, supporting reproducible results.
Why Provenance Matters for Reproducible Research
Batch-to-batch differences in synthesis and purification can change how a reference agonist behaves in an assay. Traceable provenance and consistent analytical documentation reduce that variability, making sourcing part of sound experimental design rather than a formality.
Key Takeaways for Researchers
PT-141 (bremelanotide) is a cyclic melanocortin peptide studied primarily as an MC4R-focused reference agonist in preclinical neuropharmacology. Its cyclic structure supports stability and selectivity. For laboratory work, identity confirmation, purity verification, and careful storage are the practical priorities, and all use should remain within a controlled research setting.
Frequently Asked Questions
What is PT-141 used for in research? It is studied as a melanocortin-receptor agonist, particularly at MC4R, in preclinical neuropharmacology and receptor-signaling models. These are experimental applications, not established human uses.
What receptor does PT-141 target? Research focuses on the melanocortin receptors, with particular interest in MC4R, where it acts as an agonist in experimental systems.
How is PT-141 stored in a lab? Typically lyophilized, cold, dry, and protected from light, with freeze-thaw cycles minimized after reconstitution.
How is PT-141 purity confirmed? Through HPLC purity analysis and mass spectrometry for identity, supported by content analysis, all documented on a certificate of analysis.
Is PT-141 approved for human use? No. As discussed here, it is a research compound for research use only, not a drug or supplement, and it is not intended for human or animal use.
This article is for educational purposes only. PT-141 is a research compound intended strictly for laboratory research use and is not for human or animal use, diagnosis, or treatment.
